Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P) 1 is strongly associated with SNPs in IRF6 (interferon regulatory factor 6) 2 . Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G4A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P ¼ 1 Â 10 À11 ) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.
Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P) 1 is strongly associated with SNPs in IRF6 (interferon regulatory factor 6) 2 . Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G4A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P ¼ 1 Â 10 À11 ) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.
Mutations in IRF6 cause Van der Woude syndrome, a rare mendelian clefting disorder with lower lip pits in B85% of affected individuals 3 . The remaining 15% of individuals with Van der Woude syndrome have CL/P with no lip pits and are clinically indistinguishable from the common, isolated or NSCL/P with a birth prevalence of B1/700 livebirths. Significant association between SNPs in and around IRF6 and NSCL/P was previously shown in multiple populations 2 and independently replicated [4] [5] [6] [7] . One particular SNP (rs2235371, G4A) that changes valine to isoleucine at amino acid position 274 (V274I) was found to be significantly associated with NSCL/P in Asian and Amerindian populations. The associated G allele is evolutionarily conserved and its frequency is very high in European and African populations (497%). This SNP may be a surrogate for a true etiologic variant as it is located in an approximately 140-kb linkage disequilibrium (LD) block. Sequencing of the protein-coding and splice-site regions of IRF6 in 160 individuals with NSCL/P did not detect any obvious causative variants 2 . On the basis of these observations, we postulated that an etiological variant was in strong LD with the G allele and would reside in a regulatory element of IRF6 within the LD block.
To identify potential cis-regulatory elements for IRF6, we obtained and aligned genomic sequences orthologous to a 500-kb region encompassing human IRF6 from 17 vertebrate species. Sequences were first aligned to the human reference sequence and then searched for multispecies conserved sequences (MCSs). A total of 407 MCSs, with an average size of 61 bp, were identified within the 500 kb examined, and their distribution in protein-coding and untranslated regions is shown in Supplementary Table 1 online.
We next selected 41 noncoding MCSs contained within the 140-kb haplotype block of strong LD as most likely to contain one or more SNPs contributing to our previous association with NSCL/P. These sequences were located in the introns and in the 5¢ and 3¢ flanking sequences of IRF6 (Supplementary Table 1 ). The 41 MCSs ranged in size from 25 bp to 168 bp and were screened for potential causative variants in 184 individuals with NSCL/P from Iowa and the Philippines by direct sequencing (B7.5 kb of sequence in total). Overall, 18 variants were detected, of which 12 were previously identified (in dbSNP). To determine whether the frequencies of the detected variants were different in cases versus controls we sequenced an equal number of unaffected individuals from matched populations. Among 18 variants, only 3 SNPs (all located within a 50-bp segment in MCS-9.7; Fig. 1a hypothesis-generating to identify likely mutation sites). The common ancestral alleles of two of these SNPs, -14474A4G and -14523G4A, were overrepresented in cases compared with the controls from the Iowa population (w 2 ¼ 6.12, degree of freedom (d.f.) ¼ 1, P ¼ 0.01) and were in complete LD (r 2 ¼ 1) with each other and with the G allele of rs2235371. The remaining SNP rs642961, located between these two SNPs, also showed significant
04) between cases and controls from the Iowa population. In contrast to -14474A4G and -14523G4A, the associated allele of rs642961 is the derived allele A, whereas its ancestral G allele is strongly conserved across 12 different vertebrates (Fig. 1a) . Transcription factor binding site analysis predicted that the risk allele would alter a binding site for Results shown are for proband nuclear families only. a Likelihood ratio test (LRT) of risks of specified haplotypes: under the null, the risks are set equal; under the alternative, the risks are assumed not equal (freely estimated); all other haplotype risks are freely estimated under both null and alternative (background/nuisance parameters). b Odds ratio of the estimated haplotype effects associated with the specified haplotype compared to the effects associated with the reference haplotype.
AP-2a, a transcription factor involved in craniofacial development 8 . Moreover, mutations affecting AP-2a cause branchio-oculo-facial syndrome 9 , which has overlapping features with Van der Woude syndrome such as orofacial clefting and occasional lip pits, thus making rs642961 a good candidate for an etiological variant. We then assessed association between nonsyndromic clefts and SNPs rs642961 (G4A) and rs2235371 (G4A, encoding V274I) using family-based transmission disequilibrium tests (TDT) in 432 Norwegian, 479 Danish, 606 other European (Netherlands, UK, Italy) nuclear families from the EUROCRAN Project, 196 large multiplex Filipino families and 490 Filipino trios ( Table 1) . The CL subset consists of those families in which one or more of the affected family members have cleft lip alone, whereas all affected family members in the CLP subset have cleft lip and cleft palate. The CL/P subgroup is a combination of the CL and CLP subgroups. The families in the PALATE subgroup have at least one affected individual with cleft palate alone. Parent-to-offspring observed transmission values were compared with the expected transmission values using the familybased association test (FBAT) 10 for each SNP and for haplotypes of the two SNPs. Table 1 presents the results for the CL/P group by population. We found statistically significant overtransmission of the A allele at rs642961 to affected individuals in all populations separately and combined: Norwegian (P ¼ 0.005), Danish (P ¼ 0.0001), EUROCRAN (P ¼ 0.003), all European populations (P ¼ 3 Â 10 À8 ), Filipino (P ¼ 6 Â 10 À6 ) and all populations combined (P ¼ 1 Â 10 À11 ).
Haplotype TDT analysis showed that rs642961 splits the G allele of rs2235371 into two distinct haplotypes, GG and GA. Haplotype GA showed strong evidence of overtransmission (P ¼ 8 Â 10 À13 ) in the CL/P group, whereas haplotypes GG, AG and AA were significantly undertransmitted, that is, negatively associated (P ¼ 0.005, P ¼ 4 Â 10 À9 and P ¼ 0.004, respectively; Table 1) . These haplotype results demonstrate a strong association with the haplotype containing the rs642961[A] allele and suggest that there is not an independent association with the G allele of rs2235371. Furthermore, the association with haplotype GA was stronger in the CL subset (P ¼ 5 Â 10 À11 ) than in the CLP subset (P ¼ 0.0004), and there was no association in the PALATE subset (P ¼ 0.79). These patterns were consistent across populations.
We next used conditional haplotype analyses in the proband nuclear families derived from each extended kindred, by cleft subgroups ( Table 2) . First we contrasted the risk of the GA haplotype to that of the GG haplotype to test further whether rs2235371 has an association with clefting independent of the rs642961 association. In every population, plus combined Europe and total, GA had a significantly increased risk over GG in the CL/P and CL groups (that is, OR 4 1.0), lending further support to the notion that the G allele of rs2245371 does not have an association with clefting independent of the rs642961 A allele association with CL/P and CL. In contrast, there were no significant differences in GA versus GG risk in the PALATE subgroup for any population. The CLP subgroup showed significant results in Europeans but not Filipinos.
We then contrasted haplotype GG versus AG to determine whether the association with rs642961 completely accounted for the IRF6 association ( Table 2) . For these comparisons, the only significant findings were in the Filipino population, suggesting that rs642961 is etiologic in the European populations but that there may be additional alleles leading to clefting in the Filipinos. Notably, this finding in the Filipinos was most significant in the CLP and CL/P groups (P ¼ 0.0009 and P ¼ 0.0001, respectively), and borderline in the CL group (P ¼ 0.02). Overall, the haplotype results suggest that there may be one or more additional alleles present on the G haplotype background also contributing to clefting and with perhaps a greater effect on CLP than CL. Multiple functional SNPs have previously been reported in the IRF5 gene, encoding another member of the IRF family of transcription factors and associated with systemic lupus erythematosus 11 . Thus, additional risk variants in IRF6 might increase the risk of clefting independently or synergistically with rs642961.
In order to assess possible dosage effects of rs642961[A], we used log-linear modeling to determine the relative risks for rs642961 genotypes within each phenotype and population (Table 3) in the proband triads. FBAT association analyses in the proband trios ( Table 3 ) had the same patterns of significance as in the entire extended kindred dataset ( Table 3) . We also observed this dosage effect trend in most of the individual populations for the CL, CLP and CL/P phenotypic subgroups, whereas there was no association and no allele dosage effect in the PALATE subgroup.
To determine the population impact of the risk allele between cases and controls we genotyped rs642961 in two cohorts of unbiased case collections born within defined time periods from Denmark all cases combined than in controls from both groups. Consistent with the transmission results in the family data, the frequency of the risk allele was significantly higher in cases with cleft lip only (CLO) versus other cleft phenotypes and the CLO odds ratio was 1.99 (95% CI ¼ 1.54-2.57, P ¼ 3 Â 10 À7 ; Table 4 ). The fraction of NSCLO cases attributable to the A allele of rs642961 is 18% in these two populations combined. Similar to the transmission results in the family data, although the risk allele showed a nonsignificant trend toward association with CLP (OR ¼ 1.23, 95% CI ¼ 0.97-1.57, P ¼ 0.08), it showed no association with cleft palate only (CPO; P ¼ 0.1).
Previously, most studies have combined CLO and CLP into common etiologic and recurrence risk groups 14 . Recent epidemiologic evidence suggests that CLO might be separable 15 . In the current study there was a clear separation of risk and transmission patterns between the CLO and CLP groups based on rs642961 genotype. Further, we recently updated our large genome-wide linkage analysis 16 of NSCL/P to double the sample size (now 861 multiplex families) and found genome-wide significant linkage (lod score ¼ 3.34) with the IRF6 region attributable to the CLO subset. We also determined the worldwide distribution of rs642961 by genotyping the samples from the CEPH diversity panel. African populations have the lowest derived allele frequency (0.11), and Native Americans have the highest (0.27), whereas European and Asian frequencies differ on the basis of geographic origins (Supplementary Table 2 online). These frequency differences broadly mirror the observed prevalence differences in orofacial clefting across these populations and, coupled with the high frequency of this risk allele in all populations, suggest the possibility of a selective advantage for this or a linked variant in Asian and European groups 17 .
To determine whether rs642961 affects DNA binding by transcription factor AP-2a we carried out electrophoretic mobility shift assays (EMSA) using human recombinant AP-2a protein and fluorescently labeled oligonucleotide probes containing rs642961 (Fig. 1b) . The oligonucleotide probe containing the G allele robustly bound the AP-2a protein, whereas an oligonucleotide probe containing the A allele did not bind at all (Fig. 1c) . Increasing the amount of unlabeled G probe efficiently competed with the binding of the labeled G probe. In contrast, increasing amounts of unlabeled A probe had no effect on the binding activity of the labeled G probe, indicating a specific interaction between the G allele and AP-2a. Further analysis of the region surrounding rs642961 revealed three additional highly conserved AP-2a binding motifs ( Supplementary  Fig. 1 online) . A chromatin immunoprecipitation (ChIP) assay, coupled with quantitative real-time PCR, showed 2.6-fold enrichment for the MCS-9.7 region in AP-2a antibody-immunoprecipitated chromatin relative to IgG-precipitated chromatin from HaCaT keratinocyte cells homozygous for rs642961 [G] (Fig. 1d, plot I) . In cells overexpressing AP-2a, the MCS-9.7 chromatin enrichment was tenfold (Fig. 1d, plot III) . No difference in relative enrichment was observed for a control region devoid of AP-2a binding sites in either cells (Fig. 1d, plots II-IV) . Taken together, these results demonstrate that the MCS-9.7 region is a direct target of AP-2a in vivo.
Next, we assessed the regulatory activity of MCS-9.7 in a transgenic mouse enhancer assay. We inserted 775 bp (chr. 1:208055673-208056447, UCSC hg18) of human genomic sequence that contains the entire MCS-9.7 region into a previously described expression vector 18 in which the lacZ reporter gene is driven by a minimal mouse heat-shock promoter. Eight out of nine F 0 embryos reproducibly expressed lacZ in the ectoderm covering facial prominences, predominantly at the fusion sites between the prominences, and in developing limbs and the branchial arch (Fig. 2) , consistent with known sites of endogenous craniofacial Irf6 expression at this developmental stage 19 and suggesting that the MCS-9.7 region functions as an enhancer element for IRF6. Three-dimensional digital imagery and virtual sections of LacZ-stained whole-mount embryos captured using optical projection tomography 20 are available in Supplementary Videos 1-3 online.
In order to assess the effects of rs642961 on IRF6 expression, we carried out luciferase reporter assays in a human foreskin keratinocyte cell line. The risk haplotype consistently increased the luciferase expression more than the non-associated haplotypes did, but the difference did not reach statistical significance ( Supplementary Fig. 2  online) . Previous studies have demonstrated that some regulatory polymorphisms do not always reflect their in vivo effects in cell culture-based assays 21 , particularly for developmental genes that show temporal and tissue-specific expression patterns. Although rs642961 shows minor effects on reporter gene expression in cell culture, it is possible that it has significantly larger or even opposing effects on IRF6 expression in vivo in its native chromosomal context and/or in the presence of trans-acting variants.
Although linkage and association studies are increasingly effective in identifying loci and putative genes involved in common complex traits, the progression to identification of specific etiologic variants has proven difficult. Demonstrating that a specific variant is etiologic in what may be a large haplotype block with many strongly correlated SNPs requires compelling statistical evidence coupled with convincing functional data for a specific variant. Previous sequencing of candidate genes in individuals with NSCL/P has disclosed rare mutations in individual families 22, 23 , but no common causative variants have been described. In the present study we report a common single point mutation in a gene regulatory element that confers an 18% attributable risk for isolated cleft lip.
METHODS
Subjects. We obtained written informed consent from all participants in compliance with The University of Iowa Institutional Review Board (approval nos. 199804080 and 199804081). The Danish family data consisted of 362 NSCL/P nuclear pedigrees, with 23 affected (step) and 845 unaffected (step) siblings for a total of 1,624 individuals. The Danish case control data consisted of 107 cases and 495 controls unrelated to the family data. The Norwegian family data consisted of 314 NSCL/P nuclear pedigrees, with 1 affected sibling, 1 unaffected sibling and 237 siblings with unknown affection status for a total of 1,181 individuals. The Norwegian case-control data consisted of 298 cases who were the probands from the families plus 108 cases with CPO and 750 controls unrelated to the family data. The Filipino data consisted of 203 multiplex NSCL/P extended pedigrees containing 932 nuclear families for a total of 2,797 individuals. For some analyses, CLO and CLP subsets were analyzed from the total Filipino families where the CLO subset consists of those families in which one or more affected individual has CLO (number of CLO families ¼ 121), versus the CLP subset in which all affected family members have CL plus CP (number of CLP families ¼ 70). The EuroCran data consisted of 432 nuclear trios (263 from The Netherlands, 105 from the UK and 64 from Italy), for a total of 1,296 individuals.
Comparative genomic sequence analysis. Sequences of the genomic region encompassing the IRF6 gene for human and other organisms listed in Supplementary Table 3 online were compiled from publicly available whole-genome datasets. Orthologous sequences from rabbit, pig, bat, armadillo and elephant were generated specifically for this study using targeted BAC-based mapping and sequencing strategy 24 (Supplementary Table 3 ). MultiPipMaker 25 was used to align these sequences with the 'single coverage' option that eliminates some matches caused by duplications and the 'search both strand' option. We identified MCSs using the WebMCS program, which calculates a conservation score for each base in the reference sequence by analyzing windows of 25 nucleotides across MultiPipMaker-generated multispecies sequence alignment on the basis of an algorithm previously developed 26 .
Prediction of transcription factor binding motifs. We used the Transcription Element Search System (TESS), which is linked to the TRANSFAC, JASPAR, IMD and CBIL-GibbsMat databases, to scan MCSs for previously reported transcription factor binding sites. Genotyping and statistical analysis. Genotyping was carried out using TaqMan SNP Genotyping Assays on the ABI Prism 7900HT machine and analyzed with SDS 2.2 software (Applied Biosystems). The genotyping success rate was extremely high (498%) and the mendelian error rate was less than 2% (some of which may be due to potential deletions in this region). For the family data, we carried out SNP and haplotype TDT analyses with the FBAT program (v.1.7.3), using the -e option of the program to account for multiple sibs in a family or multiple nuclear families in a pedigree. With a Bonferroni correction, the a level for significance of the association analyses was calculated as 0.05/32 ¼ 0.0016. In order to assess possible dosage effects of the associated allele, we fit log-linear models with genotype and imprinting effects to the proband-parent triads using the SAS version of the LRT program 28 . We then used likelihood ratio tests of the model parameter effects to estimate the relative risks (with 95% CI) for overtransmission of one versus two associated alleles (A allele) at SNP rs642961. In these same proband-parent triads plus proband siblings if available (that is, proband nuclear families), we compared the risk associated with haplotype GA to that of haplotype GG, as well as the risks associated with haplotypes AG versus GG. We also estimated the OR of the effects due to a particular haplotype with respect to a specific reference haplotype, and the associated 95% CI. The haplotype relative risk and OR were calculated using LRT methods, as implemented in the software Unphased 29 . In the case-control data, OR with Fisher's exact P values were calculated using SAS v.9.1.3 software. The population attributable risk percentage (PAR%) was calculated using the formula PAR% ¼ (P e (RR-1)/RR) Â 100, where P e is the prevalence of the allele in cases, and RR is the relative risk. The OR was used as a proxy for the RR. The Danish case-control data was from the singleton cases and controls that were ascertained separately from the cleft family data. The Norwegian case-control data consisted of the probands from the cleft family data and the probands from a control family data.
EMSA. We purchased infrared dye (IRDye-700) end-labeled and unlabeled oligonucleotide probes (Fig. 1b) from LI-COR Biosciences and IDT, respectively. We carried out EMSAs by using the LI-COR EMSA Kit, following the protocol described in Supplementary Methods online.
ChIP assay. Protein cross-linked chromatin from B2 Â 10 7 HaCaT keratinocyte cells uninfected or infected with a human AP-2a-expressing adenovirus (Ad-AP-2a) was isolated as detailed previously 30 . We then determined the amount of immunoprecipitated target region by SYBR Green (Applied Biosystems) quantitative real-time PCR with primers specific for the target sequence in MCS-9.7 and control region (Supplementary Methods and Table 4 ). Real-time PCR was carried out in triplicate and amplification of the target amplicon was monitored as a function of increased SYBR Green fluorescence. We set an analysis threshold and computed the cycle threshold for each sample. Fold enrichment of target sequence was calculated using the formula fold enrichment ¼ 2 (x-y) , where x is the cycle threshold of the sample immunoprecipitated with AP-2a-Ab, and y is the cycle threshold of the sample immunoprecipitated with IgG.
Luciferase assay. For the luciferase reporter assay, we generated reporter constructs by inserting a 540-bp genomic segment (chr. 1:208055787-208056326, UCSC hg18) containing the entire MCS-9.7 region upstream of firefly luciferase ORF driven by the SV40 promoter. DNA samples from individuals homozygous for -14474A4G, -14523G4A and rs642961 variants were PCR amplified and cloned into the pGL3-Basic and pGL3-Promoter vectors (Promega) in both orientations. Luciferase assays were done in HFK cells as described in Supplementary Methods. The assays were performed in triplicates in seven independent experiments on separate days. The relative luciferase activity was calculated by dividing the luminescence of firefly luciferase activity by that of the co-transfected Renilla luciferase, and pairwise comparisons of luciferase expression level from different constructs were done using two-tailed Student's t-test.
Note: Supplementary information is available on the Nature Genetics website.
